Science Sun Pharm released its first-quarter performance, with a net profit attributable to the parent company of 39.97 million yuan

According to the Zhitong Finance APP, Science Sun Pharm (300485.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 92.5365 million yuan, a year-on-year decrease of 15.52%. The net profit attributable to shareholders of the listed company was 39.97 million yuan, and the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.19 million yuan, a year-on-year decrease of 92.15%